This is a non-core endpoint: only basic statistics are computed.
Scleritis and episcleritis in diseases classified elsewhere
DOID EFO MESH SNOMED Endpoint Browser
H7_SCLERITISINOTH
eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
H19.0*, H19.0*A18.5, H19.0*A52.79, H19.0*A69.2, H19.0*B02.3
Cause of death: ICD-10
H19.0*, H19.0*A18.5, H19.0*A52.79, H19.0*A69.2, H19.0*B02.3
2 out of 7 registries used, show all original rules.
34
Check minimum number of events None
34
Include endpoints None
34
Remove individuals based on genotype QC
33
H7_SCLERITISINOTH
Control definitions
Control exclude
H7_SCLERACORNEA
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Scleritis and episcleritis in diseases classified elsewhere
based on the number of shared cases.
Broader endpoints:
- Scleritis and episcleritis
- Keratitis
- Disorders of sclera, cornea, iris and ciliary body
- Diseases of the eye and adnexa
- Any operation in hilmo
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 33 | 21 | 12 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 59.75 | 55.60 | 67.00 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: H7_SCLERITISINOTH – Scleritis and episcleritis in diseases classified elsewhere
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Scleritis and episcleritis in diseases classified elsewhere
↥Endpoint not on priority list, no data to show.